Fundz

Lyndra Therapeutics Completes $60.5 Million Series C Financing

PRIVATEJun 24, 2021

Amount Raised

$60.5 Million

Round Type

Series C

WatertownBiotechnology

Description

Lyndra Therapeutics, a clinical-stage biotechnology company pioneering a novel technology platform that transforms daily pills into once-weekly to monthly oral treatment options, today announced the closing of its $60.5 million Series C financing. The proceeds of the round, led by new investor, AIG Investments, an affiliate of American International Group, Inc. (‘AIG’), will advance Lyndra’s lead product candidate into pivotal trials as the Company prepares for commercialization in the U.S. In parallel, the Company is expanding its central nervous system (CNS) pipeline assets and actively evaluating high value partnerships across a broad range of disease states.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Lyndra Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • CytoImmune Therapeutics, Inc. raised $37M on August 6, 2021.
  • Lanier Biotherapeutics raised $805K (Seed) on August 6, 2021.
  • Singletto raised $50K on August 6, 2021.
  • CHONEX raised $5.8M on August 6, 2021.
  • Reimagine Care raised $5.3M on August 6, 2021.
  • Unravel Biosciences, Inc. raised $500K (Seed) on August 6, 2021.

Who to call at Lyndra Therapeutics, Inc., and when

A new round usually means Lyndra Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Lyndra Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lyndra Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lyndra Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lyndra Therapeutics, Inc.

Location

65 GROVE STREET, SUITE 301

Watertown, Massachusetts, United States

About

Lyndra Therapeutics is pioneering the first-ever oral, ultra-long-acting, extended-release therapies, which have the potential to fundamentally change the way people take medicine by enabling patients to take a pill once a week rather than daily. The Company’s breakthrough Extended-Release Oral Capsule is designed to provide consistent drug levels for an entire week or as long as a month, from one, normal-sized capsule – something no oral therapy has ever achieved before. Lyndra’s robust pipeline is made up of therapies with established and well-known safety profiles across a number of disease areas in which non-adherence is known to be a significant driver of outcomes, including schizophrenia and other central nervous system diseases, diabetes, cardiovascular disease and opioid use disorder, among others. The Company is also committed to advancing its platform across new chemical entities and a variety of critical global and public health opportunities alongside partners such as the Bill & Melinda Gates Foundation and through funding from the NIH.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lyndra Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Lyndra Therapeutics, Inc.'s next move

See what Strategic adds

Lyndra Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.